Seeing Is Believing
Currently out of the existing stock ratings of Catherine Ramsey Schulte, 86 are a BUY (86%), 14 are a HOLD (14%).
Analyst Catherine Ramsey Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 70.87% that have a potential upside of 28.95% achieved within 136 days.
Catherine Ramsey Schulteās has documented 208 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRVI, Maravai Lifesciences HoldingsĀ at 08-Nov-2024.
Analyst best performing recommendations are on ILMN (ILLUMINA).
The best stock recommendation documented was for ILMN (ILLUMINA) at 4/15/2020. The price target of $310 was fulfilled within 2 days with a profit of $15.71 (5.34%) receiving and performance score of 26.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$150
$12.28 (8.92%)
$147
4 days ago
(13-Dec-2024)
6/7 (85.71%)
$12.28 (8.92%)
92
Buy
$155
$17.28 (12.55%)
$135
8 days ago
(09-Dec-2024)
13/16 (81.25%)
$10.84 (7.52%)
403
Sell
$135
$-2.72 (-1.98%)
$145
20 days ago
(27-Nov-2024)
5/10 (50%)
$-3.74 (-2.70%)
99
$145
$7.28 (5.29%)
$135
2 months 16 days ago
(01-Oct-2024)
4/4 (100%)
$-1.56 (-1.06%)
17
Buy
$200
5 months 20 days ago
(27-Jun-2024)
8/9 (88.89%)
$28.88 (16.88%)
196
Which stock is Catherine Ramsey Schulte is most bullish on?
Which stock is Catherine Ramsey Schulte is most reserved on?
What Year was the first public recommendation made by Catherine Ramsey Schulte?